📌 Key Takeaways
- Topic: Silicon Dioxide in Supplements: Purpose, Safety and Dosage Limits
- Keywords: fumed silica supplier
- Published: 2026-11-20 05:27:41
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Hollow Glass Microspheres vs Hollow Silica: Lightweight Fillers Compared
- 600 Mesh Silica: Particle Size, Specifications and Common Applications
- 325 Mesh Silica: Particle Size, Specifications and Common Applications
- Silica Supplier Mexico: Sourcing Options, Producers and Import Tips
- Silica Wholesale: How to Buy in Bulk and Get the Best Price
What Is an Antiblock Agent for Film? How Silica Prevents Film Blocking
What is silica (SiO₂)?
silica gel beads Chakraborti, S., Basu, R. N. & Panda, S. Vertically aligned silicon nanowire array decorated by Ag or Au nanoparticles as SERS substrate for bio-molecular detection. Plasmonics 13, 1057-1080 (2018). Article CAS Google Scholar
What is the difference between fumed silica and precipitated silica?
silica COA Yan, H., Yang, H., Li, K., Yu, J. & Huang, C. Effects of chlorhexidine-encapsulated mesoporous silica nanoparticles on the anti-biofilm and mechanical properties of glass ionomer cement. Molecules 22, 1225 (2017). Piece PubMed Central Google Scholar
What drives silica raw material prices?
The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.